Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 24Breast Neoplasms 8Neoplasms 3Sleep Wake Disorders 1Salivary Gland Neoplasms 1Osteoporosis 1Neoplasm Metastasis 1Fatigue 1

Interventions

Zoledronic Acid 8Letrozole 4Vitamin D 3Calcium 3Risedronic Acid 2Nutrition Assessment 2Denosumab 2Cholecalciferol 2Calcium Gluconate 2Calcium Carbonate 2Aromatase Inhibitors 2parathyroid hormone-related peptide (1-36) 1Technetium 1Resistance Training 1Radiotherapy 1Observation 1Kyphoplasty 1Ibandronic Acid 1Gonadotropin-Releasing Hormone 1Geritol 1Calcium Citrate 1Anastrozole 1Alendronate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Osteoporosis × Gonadotropin-Releasing Hormone × Clear all
NCT00329797 2017-11-29

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Radiation Therapy Oncology Group

Phase 3 Completed
109 enrolled 8 charts
Genitourinary

Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡